A Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic Cancer

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Cascadian Therapeutics Inc.

ClinicalTrials.gov Identifier:

NCT00736372

First received: August 13, 2008

Last updated: March 21, 2013

Last verified: March 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2009
Primary Completion Date:	August 2009 (Final data collection date for primary outcome measure)